Old National Bancorp’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Old National Bancorp’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,500	Closed	-$462K	–	619
2025 Q1	$462K	Sell	3,500 -1,300	-27%	-$162K	0.01%	347
2024 Q4	$401K	Sell	4,800 -1,500	-24%	-$123K	0.01%	433
2024 Q3	$461K	Hold	6,300	–	–	0.01%	403
2024 Q2	$431K	Sell	6,300 -14,485	-70%	-$1M	0.01%	396
2024 Q1	$1.44M	Hold	20,785	–	–	0.03%	252
2023 Q4	$1.49M	Sell	20,785 -817	-4%	-$47K	0.04%	249
2023 Q3	$1.13M	Sell	21,602 -3,535	-14%	-$206K	0.03%	283
2023 Q2	$1.59M	Sell	25,137 -1,173	-4%	-$73.1K	0.05%	249
2023 Q1	$1.42M	Sell	26,310 -4,592	-15%	-$222K	0.04%	265
2022 Q4	$1.64M	Sell	30,902 -19,874	-39%	-$996K	0.05%	248
2022 Q3	$2.36M	Sell	50,776 -1,221	-2%	-$63.8K	0.08%	204
2022 Q2	$2.97M	Buy	+51,997	New	+$2.95M	0.1%	181

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Old National Bancorp's ITCI Position: Q2 2025 in Review

Old National Bancorp sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,500 shares — an estimated $462K sold.

Old National Bancorp first reported a position in ITCI in Q2 2022 and held it in 12 quarters. The position peaked at $2.97M in Q2 2022. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Old National Bancorp reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Old National Bancorp sold 3,500 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $462K.
Old National Bancorp first reported a position in Intra-Cellular Therapies Inc. in Q2 2022 and held it in 12 quarters.
Old National Bancorp's Intra-Cellular Therapies Inc. position peaked at $2.97M in Q2 2022.
3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Old National Bancorp's 13F filing for Q2 2025, filed 22 Jul 2025.